The GLP-1 environment is continually evolving, with changes to policies, insurance coverage, and delivery mechanisms expanding access and lowering costs for consumers, said Steve Kramer, VP of product innovation at Numerator
In April and December of 2022, respectively, the FDA determined that semaglutide and tirzepatide were in short supply, opening the floodgates for compounding pharmacies and outsourcing facilities to manufacture, distribute and market copies, typically sold through telehealth companies, medical spas and wellness centers
Constipation GLP-1 medications slow gastric emptying, which can lead to constipation
A slightly higher number of hospitalizations occurred with semaglutide, but serious adverse event rates were similar to placebo
Those test cups
It can assist in precise cancer diagnosis, targeted drug delivery, and improved therapeutic efficacy [108, 109]